A rapid bioassay for gentamicin levels in.serum was developed by using a strain of Klebsiella pneumoniae that has multiple resistance to antibiotics. Assays were comparable when performed on either small or large petri plates, and results were available in 2 to 4 h. Studies showed an overall recovery of 97.6% for gentamicin alone or 104.5% in the presence of commonly used antibiotics. The procedure can be performed without the need to inactivate other antibiotics that may be present in the serum sample.
Several studies have now been reported which define methods for the rapid assay of gentamicin in body fluids (1, 6, 9, 10, 12, 13, 19, (20) (21) (22) (23) (24) (25) . The bioassay methods use a test organism susceptible not only to gentamicin but also to many antibiotics commonly used therapeutically in combination with gentamicin, thus requiring some procedure for the inactivation of these other antibiotics when this is possible. The other methods necessitate working with labeled substrate or with labeled gentamicin and antibody against gentamicin. Each of these methods either requires a sophistication beyond the scope of many laboratories or presents limitations which prevents its use in patients in certain clinical circumstances.
We report here a method of assay employing a stable, multiple-antibiotic-resistant Klebsiella pneumoniae. This method permits the rapid assay of gentamicin in most patients being treated with gentamicin alone or in combination with other antibiotics. The method eliminates the need for inactivation of accompanying antibiotics and reagents not commercially available.
MATERIALS AND METHODS
Organism used in preparation of assay plates. The strain of Klebsiella (University of Minnesota, K-1296) used to seed the agar assay plates was originally isolated in April 1968 and has been used to assay serum gentamicin levels since August 1971. Biochemical identification of the organism was performed by using the methods outlined by Edwards and Ewing (5) . The antibiotic susceptibility pattern of Klebsiella 1296 was determined both by the disk diffusion method of Bauer, Kirby, Sherris, and Turck (2) and by minimal inhibitory concentrations (MICs) by using a standardized twofold dilution technique in Mueller-Hinton broth by employing an inoculum of 10' to 106 organisms per ml. The Klebsiella 1296 serotype was determined by the methods described by Edwards and Ewing (5) .
Preparation of assay plates. Antibiotic medium no. 11 (Difco) was adjusted to pH 7.9 ± 0.1, dispensed into 25-ml amounts, and autoclaved. The samples were stored at 4 C for up to 1 month. The appropriate number of tubes of agar were melted and cooled to 50 C as needed for the assay of gentamicin. A 0.4-ml sample of a well-mixed overnight Trypticase soy broth (BBL) culture of Klebsiella 1296 was added to 25 ml of melted, cooled agar. Alternately, 0.4 ml of a heavily inoculated 5-h broth culture could be used to seed the agar. The inoculum contained on the average 1.72 x 10' colony-forming units (CFU) per ml (overnight cultures: mean = 1.79 x 10' CFU/ml; 5-h cultures: mean = 1.61 x 109 CFU/ml) as determined by 10 successive replicate counts. For the assay of gentamicin in a single specimen, 9 ml of the well-mixed, seeded agar was pipetted into each of two 100 by 15 mm plastic petri dishes. When several assays were to be performed, 25 Recoveries. To determine the ability of the assay procedure to recover gentamicin, known amounts of gentamicin were added to human sera. These sera were then assayed for gentamicin by using the Klebsiella 1296 bioassay, and the percentage of recovery of the added amount was determined. The recovery, then, is a measure of the method's accuracy.
Recoveries were performed by adding 0.02 ml of concentrated stock solutions of gentamicin in sterile, distilled water (500, 400, 300, 200, and 100 yg/ml) to 0.5 ml of human serum. Twenty-five recoveries using large assay plates were performed on normal, singledonor human serum, and another 25 were performed on serum taken from a Gambro dialyzer. An additional 10 recoveries by using small plates were performed on patients' sera on which a gentamicin assay had been requested.
Recovery of gentamicin in the presence of other antibiotics was tested by adding 0.01 or 0.02 ml of concentrated antibiotic to 0.5 ml of serum containing 10.0 gg of gentamicin per ml. Ampicillin was tested at a final concentration of 200 gg/ml. Carbenicillin, cephalothin, chloramphenicol, clindamycin, kanamycin, methicillin, penicillin, and tetracycline were tested at a concentration of 100 Ag/ml. In addition, cephalothin was tested at 300 and 500 ug/ml and carbenicillin and penicillin at 1,000 ,g/ml.
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All recovery specimens were assayed by using the routine procedure without modification. ,ug/ml (Fig. 1) . This allows the use of undiluted patient serum in the assay whether one expects therapeutic or toxic levels. (21) , radioimmunoassay (9) , and bioassay (1, 6, 10, 12, 13, 19, 20, (22) (23) (24) (25) . The adenylation method and the radioimmunoassay have the disadvantages that (i) they employ reagents not now obtainable commercially and (ii) they require the use of equipment and techniques not available to many laboratories. The bioassays avoid these problems. The bioassays using a measurement of pH changes (6, 12, 13) have the disadvantage of using relatively more serum than do the other bioassays. Even without replicates, 0.4 ml of serum is required in the bioassay using a Proteus species in a ureacontaining broth (13) (14) (15) . This requirement may prove critical in pediatric specimens. Furthermore, the Proteus bioassay of gentamicin shares the major limitation of some of the disk diffusion assays; it is not applicable in the presence of certain antibiotics (e.g., chloramphenicol and kanamycin) (15) . The fully evaluated disk diffusion assays currently available employ organisms susceptible to many antibiotics. Although some of these antibiotics can be inactivated by the appropriate ,B-lactamase (available from Whatman Biochemicals, Ltd., Springfield Mill, Maidstone, Kent, England), the presence of others (chloramphenicol, kanamycin, clindamycin, tetracycline, and erythromycin) precludes the measurement of gentamicin in serum containing the corresponding combinations of antibiotics. Although other investigators have reported using multiply resistant organisms in the bioassay (1, 17, 18) , only Alcid and Seligman have presented data obtained with such an organism to allow evaluation of the method. The recovery studies with Klebsiella 1296 indicate the applicability of the method for routine laboratory use.
RESULTS
The recoveries of gentamicin from serum from a Gambro dialyzer point up the need for caution in accepting specimens for gentamicin assay. The temptation to draw postdialysis specimens from the dialyzer tubing rather than On sera from patients in renal failure who have been on prolonged cephalothin therapy, the use of,-lactamase is recommended, because one can anticipate the possibility of very high serum cephalothin levels in these patients (7, 16) . However, even an enzyme preparation with low activity is adequate, because it is not necessary to inactivate all of the cephalothin present.
Dilution of patient serum either with enzyme or as routine procedure is to be avoided if at all possible, especially when dealing with small amounts of specimen. The errors inherent in any bioassay procedure are magnified when results are multiplied by a dilution factor. The dose response of Klebsiella 1296 to gentamicin allows the use of undiluted sera in the bioassay.
Whether or not the necessity of carrying a fresh broth culture of Klebsiella 1296 is a disadvanatage or not depends on one's point of view. The preparation of assay plates from melted, cooled, preportioned agar takes little time. This avoids the problems of running out of plates when the assay workload is heavy or of discarding outdated plates when the workload is light. According to Reeves (17) , it is possible, if facilities are available, to store a prepared inoculum frozen in liquid nitrogen.
We feel that it is necessary to run at least a three-point standard line every time an assay is performed. This practice allows for any changes ANTIMICROB. AG. CHEMOrHER. due to variation in medium composition, either batch-to-batch or lot-to-lot variation. The use of a standard line with each assay also permits variation in the depth of the agar without significantly affecting the results. The agar depth must, of course, be kept as uniform as possible in any one plate, but plate-to-plate variations due to pipetting errors or to variations in the plastic petri dishes are obviated (4 
